Introduction {#s0005}
============

Porcine reproductive and respiratory syndrome (PRRS) is an important viral disease that brings about great economic losses to the pig industry worldwide ([@bib19], [@bib36], [@bib39]). The causative agent, PRRS virus (PRRSV), belongs to the *Arterivirus* genus of the *Arteriviridae* family, together with equine arteritis virus (EAV), lactate dehydrogenase-elevating virus (LDV) and simian hemorrhagic fever virus (SHFV) ([@bib7]). The PRRSV is divided into two major genotypes, genotype 1 (European) and genotype 2 (North American) ([@bib34]). Clinically, the viruses of the two genotypes cause a similar syndrome although they share only approximately 60% nucleotide identity of the genome ([@bib30], [@bib34]). In China, a highly pathogenic PRRSV (HP-PRRSV) of genotype 2 was recognized to cause atypical PRRS outbreaks in the pig-producing areas in 2006 ([@bib46], [@bib58]). A recent investigation indicated that the HP-PRRSV has become the dominating virus circulating in pig farms during the past years ([@bib59]).

The PRRSV genome is a single strand positive RNA with approximately 15 kb in length, which encodes at least ten open reading frames (ORFs) comprising of ORF1a, ORF1b, ORF2a, ORF2b, ORFs3--7 and the newly discovered ORF5a ([@bib10], [@bib16], [@bib22], [@bib43]). ORF1a and ORF1b, the replicase-associated genes, encode two polyproteins pp1a and pp1ab, respectively. The pp1a is predicated to be cleaved into ten non-structural proteins (Nsps) including Nsp1α, Nsp1β, Nsp2 to Nsp6, Nsp7α, Nsp7β and Nsp8 ([@bib13], [@bib14], [@bib43], [@bib49]), whereas the pp1ab can be cleaved into four Nsps, Nsp9, Nsp10, Nsp11 and Nsp12, which are considered to be involved in viral replication and genomic transcription ([@bib43], [@bib50], [@bib52]). The transframe fusion (TF) in Nsp2-coding region was recently discovered ([@bib15]). In recent years, a growing number of studies have paid much attention to the pathogenesis involved by the Nsps of PRRSV. The Nsp1, Nsp2, Nsp4 and Nsp11 of PRRSV have been shown to inhibit the induction of type I interferon and modulate host innate immune response ([@bib3], [@bib20], [@bib26], [@bib44], [@bib45]). Moreover, the Nsp1β of PRRSV was shown to interact with the cellular poly(C)-binding protein (PCBP) 1 and 2, and this interaction could facilitate viral replication and RNA transcription ([@bib2], [@bib51]). A latest study indicated that the PRRSV Nsp4 could induce apoptosis dependent on its 3C-like serine protease activity ([@bib47]).

The Nsp9 of PRRSV, a RNA-dependent RNA polymerase (RdRp), is considered to be a major component of membrane-associated viral replication and transcription complex (RTC) that is important for virus replication based on the studies of the equine arteritis virus (EAV) and comparative sequence analysis ([@bib38]). The SDD motif of Nsp9 has been recognized to be critical for its polymerase activity and virus transcription ([@bib61]). In addition to its polymerase activity, the interaction between Nsp9 and the host cellular proteins that affect viral replication is poorly understood although a recent study revealed that Nsp9 could interact with endogenous annexin A2 in PRRSV-infected MARC-145 cells ([@bib28]). Moreover, our recent publication has shown that Nsp9 and Nsp10 together not only affected the HP-PRRSV replication and growth *in vitro and in vivo*, but also contributed to its fatal virulence for piglets ([@bib29]). Thus, further exploring the interaction of Nsp9 with host cellular protein (s) is essential for understanding the roles of Nsp9 in the replication and pathogenesis of HP-PRRSV.

The retinoblastoma protein (pRb) encoded by the retinoblastoma tumor suppressor gene has been shown to modulate cell cycle and suppress human tumors ([@bib25], [@bib53]). The proteins that bind to pRb have been recognized to share a conserved motif---LxCxE ([@bib12]), which was first identified in the oncoproteins of DNA tumor viruses ([@bib6], [@bib54], [@bib55]). Some proteins of RNA viruses have been shown to bind to pRb through this motif. The interaction between the Rubella virus Nsp9 and pRb could affect viral replication ([@bib17]). In coronavirus, the endoribonuclease Nsp15 could bind to pRb, resulting in the acceleration of cell cycle progression ([@bib4]). Interestingly, the NS5B of hepatitis C virus (HCV), an RdRp, could interact with pRb and down-regulated the pRb level ([@bib33], [@bib32]). In the present study, we explored the interaction between the Nsp9 of genotype 2 PRRSV and pRb and analyzed the effect of this interaction on viral replication *in vitro*.

Results {#s0070}
=======

The Nsp9 of genotype 2 PRRSV interacted with pRb {#s0075}
------------------------------------------------

The conserved LxCxE motif is a key feature for viral proteins that bind to pRb ([@bib12]). We aligned the amino acid sequences of the Nsp9 among 17 representative strains of genotype 2 PRRSV and found that the Nsp9 of all the analyzed viruses shared an identical LxCxE motif---LACAE ( [Table 2](#t0010){ref-type="table"}). To analyze whether the Nsp9 of genotype 2 PRRSV interacts with pRb through the LACAE motif, the recombinant lentiviruses that were expressing Nsp9-GFP, Nsp9 (L415A/C417A)--GFP and Nsp9 (E419K)--GFP were constructed. MARC-145 cells were transduced with the lentiviruses and the cell lysates were immunoprecipitated with an anti-GFP mAb, and were then detected with an anti-pRb mAb by Co-IP assay. The GFP-expressing lentiviruses were used as the control. As shown in [Fig. 1](#f0005){ref-type="fig"}A, the endogenous pRb could be probed in the cells that were expressing Nsp9-GFP and Nsp9 (L415A/C417A)--GFP, whereas it could not be examined in the cells that were expressing Nsp9 (E419K)--GFP, indicating that Nsp9 interacts with pRb and the third conserved residue (E) of the LACAE motif plays a crucial role in sustaining the interaction between Nsp9 and pRb. To further confirm the interaction of Nsp9 with the exogenous pRb, HEK 293T cells were co-transfected with the Myc-pRb-tru-expressing plasmid together with the HA-Nsp9-, HA-Nsp9 (L415A/C417A)- or HA-Nsp9 (E419K)-expressing plasmids, and Co-IP assays were performed. The similar results were obtained ([Fig. 1](#f0005){ref-type="fig"}B). Our results suggest that the LACAE motif indeed plays a critical role in the interaction between the viral Nsp9 and pRb.Table 1Primers used in this study.Primer[a](#tbl1fna){ref-type="table-fn"}Sequence(5′-3′)[b](#tbl1fnb){ref-type="table-fn"}Product length (bp)Use1FAGCTTT[GTTTAAAC]{.ul}ACCATGTCTCTTGGAATTGT(*Pme*l)1914pRb-tru fragment amplification and clone1RCGCGCG[ACGCGT]{.ul}AACTTTTCTTCCCTGTTCG(*Mlu*l)2FCCG[GAATTC]{.ul}GGTCTCTTGGAAATTGTAGCCTC(*Eco*Rl)1914pRb-tru fragment amplification and clone2RCGG[GGTACC]{.ul}TCACTTTTCTTCCCTGTTCG(*Kpn*l)3FAGCTTT[GTTTAAAC]{.ul}ACCATGCTAGCCGCCAGCGGCTTGAC(*Pme*l)1920Nsp9 amplification and clone3RCGCGCG[ACGCGT]{.ul}AACTCATGATTGGACCTGAGTT(*Mlu*l)4FGGAGGA[AGATCT]{.ul}CTCTAGCCGCCAGCGGCTTGAC(*Bgl*ll)1920Nsp9 amplification and clone4RTAGTTTA[GCGGCCGC]{.ul}TCACTCATGATTGGACCTGAG(*Not*l)5FAATCTTCTTTATGAA*GC*CGCC*GC*TGCTGAGGAGCATCTACMutagenesis of Nsp9 (L415A/C417A)5RGTAGATGCTCCTCAGCA*GC*GGCG*GC*TTCATAAAGAAGATT6FTGAACTCGAATGTGCT*A*AGGAGCATCTACCGTCGTACMutagenesis of Nsp9 (E419K)6RGTACGACGGTAGATGCTCCT*T*AGCACATTCGAGTTCA[^1][^2]Table 2Amino acid alignment of the pRb-binding motif in the Nsp9 of genotype 2 PRRSV.**PRRSV strainGenBank accession noLxCx**E **motif**VR-2332AP046869.1^410^NLLYE**LACAE**EHLPS[a](#tblfna){ref-type="table-fn"}NVSL 97-7985 IA 1-4-2AF325691.1^410^NLLYE**LACAE**EYLPSP129AF494042.1^410^NLLYE**LACAE**EHLPSJA142AY424271.1^410^NLLYE**LACAE**EHLPSBJ-4AF331831.1^410^NLLYE**LACAE**EHLPSHB-1(sh)-2002AY150312.1^410^NLLYE**LACAE**EHLPSCH-1aAY032626.1^410^NLLYE**LACAE**EHLPSNB/04FJ536165.1^410^NLLYE**LACAE**EHLPSJXA1-P80FJ548853.1^410^NLLYE**LACAE**GHLPSMLV RespPRRS/ReproAF159149.1^410^NLLYE**LACAE**EHLPSPrime pacDQ779791.1^410^NLLYE**LACAE**EHLPSIngelvac ATPDQ988080.1^410^NLLYE**LACAE**EHQPSSPAF184212.1^410^NLLYE**LACAE**EHLPSTJEU860248.1^410^NLLYE**LACAE**EHLPSJXA1EF112445.1^410^NLLYE**LACAE**EHLPSHuN4EF635006.1^410^NLLYE**LACAE**EHLPSJXwn06EF641008.1^410^NLLYE**LACAE**EHLPS[^3]Fig. 1The interaction between the Nsp9 of genotype 2 PRRSV and pRb. (A) Interaction of Nsp9 with the endogenous pRb. MARC-145 cells were transduced with the lentiviruses expressing GFP, Nsp9, Nsp9 (L415A/C417A) and Nsp9 (E419K) individually. The cell lysates were immunoprecipitated with an anti-GFP mAb and followed by western blotting analysis with anti-pRb and anti-GFP antibodies. The left figure shows the Co-IP analyses of GFP, Nsp9-GFP, Nsp9 (L415A/C417A)--GFP and Nsp9 (E419K)--GFP from cell lysates and the right figure indicates the identification of GFP, Nsp9-GFP, Nsp9 (L415A/C417A)--GFP and Nsp9 (E419K)--GFP expressed in cell lysates. (*B*) Interaction of Nsp9 with the exogenous truncated pRb (pRb-tru). HEK 293T cells were co-transfected with the Myc-pRb-tru-expressing plasmids and the HA-Nsp9-, HA-Nsp9 (L415A/C417A)- or HA-Nsp9 (E419K)-expressing plasmids. The cell lysates were immunoprecipitated with an anti-HA mAb and probed with anti-HA and anti-Myc antibodies. The left figure shows the Co-IP analyses of HA-Nsp9, HA-Nsp9 (L415A/C417A) and HA-Nsp9 (E419K) from cell lysates and the right figure indicates the identification of HA-Nsp9, HA-Nsp9 (L415A/C417A) and HA-Nsp9 (E419K) expressed in cell lysates.

The Nsp9 of genotype 2 PRRSV co-localized with pRb in the cytoplasm {#s0080}
-------------------------------------------------------------------

To analyze the co-localization of Nsp9 and pRb, MARC-145 cells were co-transfected with pCMV-HA-Nsp9 and pCMV-Myc-pRb-tru. The confocal immunofluorescence assays showed that Nsp9 primarily co-localized with pRb-tru in the cytoplasm ( [Fig. 2](#f0010){ref-type="fig"}A), and the endogenous pRb also co-localized with Nsp9 in the cytoplasm of PRRSV-infected MARC-145 cells ([Fig. 2](#f0010){ref-type="fig"}B) and PAMs ([Fig. 2](#f0010){ref-type="fig"}C); whereas the endogenous pRb localized in the nucleus of mock-infected MARC-145 cells and PAMs ([Figs. 2](#f0010){ref-type="fig"}D and E).Fig. 2Co-localization of the Nsp9 of genotype 2 PRRSV with pRb in the cytoplasm. (A) Co-localization of pRb-tru with Nsp9 in MARC-145 cells. MARC-145 cells were co-transfected with pCMV-Myc-pRb-tru and pCMV-HA-Nsp9. The cells were fixed at 36 h post-transfection and processed by immunostaining with a mouse anti-HA mAb or rabbit anti-Myc polyclonal antibody and TRITC-conjugated goat anti-mouse IgG or FITC-conjugated goat anti-rabbit IgG, and were then examined by immunoconfocal microscopy. Nuclei were stained with DAPI. Co-localization of Nsp9 with the endogenous pRb in PRRSV-infected MARC-145 cells (*B*), PRRSV-infected PAMs (C), mock-infected MARC-145 cells (D) and mock-infected PAMs (E). The mock- or PRRSV-infected cells were fixed at 36 h post-infection and processed by immunostaining with a mouse anti-Nsp9 mAb or rabbit anti-pRb polyclonal antibody and TRITC-conjugated goat anti-mouse IgG and FITC-conjugated goat anti-rabbit IgG. Nuclei were stained with DAPI.

The pRb could inhibit the replication of genotype 2 PRRSV *in vitro* {#s0085}
--------------------------------------------------------------------

To investigate the effect of pRb on the replication of PRRSV, we first analyzed the effect of the exogenous pRb overexpression on the replication of PRRSV. MARC-145 cells were transduced with the pRb-tru-expressing lentiviruses, and were then infected with the PRRSV JXwn06. The virus titers were assayed. As shown in [Fig. 3](#f0015){ref-type="fig"}A, the virus titers in the pRb-tru-overexpressing group significantly reduced at the different time points compared with the control group (*p*\<0.001), indicating that the overexpression of pRb-tru can inhibit the replication of PRRSV *in vitro*. To further confirm this effect, MARC-145 cells were individually transfected with three different siRNAs specific for the pRb gene. Western blotting analysis showed that the pRb level in MARC-145 cells was effectively down-regulated by these siRNA compared with the cells transfected with the control (siCon) siRNA ([Figs. 3](#f0015){ref-type="fig"}B and C). One pair of siRNA (sipRb2) was used for subsequent experiment. The MARC-145 cells silenced with sipRb2 were infected with the virus and the virus titers were measured. The results showed that the virus titers of the sipRb2-silenced group were significantly higher than those of the control (siCon) group (*p*\<0.001 or *p*\<0.01) ([Fig. 3](#f0015){ref-type="fig"}D), indicating that silencing the pRb gene in MARC-145 cells facilitate the viral replication. The above findings suggest that pRb can inhibit the replication of genotype 2 PRRSV.Fig. 3Inhibition of genotype 2 PRRSV replication by pRb. (A) PRRSV titers in pRb-tru-overexpressed MARC-145 cells. MARC-145 cells were transduced with the lentiviruses expressing GFP and pRb-tru, respectively. The cells were infected with PRRSV JXwn06 at MOI of 0.01 at 24 h post-transduction, and the virus titers were then assayed by a microtitration infectivity assay at the indicated time points post-infection. Data are shown as means±SD of three independent experiments (\*\**P*\<0.01; \*\*\**P*\<0.001). (B) Effect of silencing the pRb gene on the abundance of endogenous pRb. MARC-145 cells were transfected with siRNA (sipRb1, sipRb2, sipRb3) and control siRNA (siCon). The cells were harvested at 48 h post-transfection and the cell lysates were probed with an anti-pRb antibody. (C) The optical density ratios of pRb/β-actin in pRb gene-silenced MARC-145 cells are shown with graphs. Data are shown as means±SD of three independent experiments (\*\*\**P*\<0.001). (*D*) PRRSV titers in pRb gene-silenced MARC-145 cells. MARC-145 cells transfected with the siRNA (sipRb2) or control siRNA (siCon) for 48 h were infected with PRRSV JXwn06 at MOI of 0.01, and the virus titers were assayed at the indicated time points post-infection. Data are shown as means±SD of three independent experiments (\*\**P*\<0.01; \*\*\**P*\<0.001).

Genotype 2 PRRSV infection down-regulated the pRb level {#s0090}
-------------------------------------------------------

The change of the pRb abundance in MARC-145 cells was analyzed following the PRRSV infection. MARC-145 cells were infected with the PRRSV, and the cell lysates were subjected to western blotting analysis. As shown in [Fig. 4](#f0020){ref-type="fig"}, the pRb abundance in PRRSV-infected MARC-145 cells reduced significantly from 36 h to 60 h post-infection compared with mock-infected cells, indicating that the PRRSV infection can down-regulate the pRb level in MARC-145 cells.Fig. 4Down-regulation of the pRb level in genotype 2 PRRSV-infected MARC-145 cells. MARC-145 cells infected with PRRSV JXwn06 at MOI of 0.01 were harvested at the indicated time points post-infection, and the cell lysates were then probed with an anti-pRb antibody. The optical density ratios of pRb/β-actin are shown with graphs.

The Nsp9 of genotype 2 PRRSV could promote the degradation of pRb by ubiquitin proteasome pathway {#s0095}
-------------------------------------------------------------------------------------------------

Several studies have shown that many viral proteins that interact with pRb promoted the pRb degradation by ubiquitin proteasome pathway ([@bib4], [@bib23], [@bib24], [@bib32]). The fact that the Nsp9 of genotype 2 PRRSV interacts with pRb and the PRRSV infection reduces the pRb level suggests that Nsp9 likely modulates the pRb level by ubiquitin proteasome pathway. To confirm this finding, MARC-145 cells were transduced with the Nsp9-expressing lentiviruses and the pRb level was examined by western blotting. Compared with the GFP-expressing cells, the pRb level was significantly down-regulated in the Nsp9-expressing cells, whereas it recovered when the cells were treated with the proteasome inhibitor MG132 ( [Fig. 5](#f0025){ref-type="fig"}A), indicating that the Nsp9 of genotype 2 PRRSV promotes the degradation of pRb. To consolidate this finding, HEK 293T cells were co-transfected with a dose-dependent increasing Nsp9 and dose-constant pRb-tru, and the pRb-tru level was examined by western blotting. The results showed that the pRb-tru level reduced gradually as the Nsp9 level increased, and it recovered in the cells treated with MG132 ([Fig. 5](#f0025){ref-type="fig"}B), indicating that the Nsp9 of genotype 2 PRRSV can down-regulate the pRb abundance by ubiquitin proteasome pathway.Fig. 5Down-regulation of the pRb level in the Nsp9-overexpressing cells by ubiquitin proteasome pathway. (A) Down-regulation of the pRb level by Nsp9 in MARC-145 cells. MARC-145 cells were tranduced with the GFP- or Nsp9-expressing lentiviruses. The cells were treated with 10 µM DMSO or MG132 and the cell lysates were then harvested for western blotting analysis. The optical density ratios of pRb/β-actin are shown with graphs. (B) Down-regulation of pRb-tru by Nsp9 in HEK 293T cells. HEK 293T cells were co-transfected with a constant dose of pCMV-Myc-pRb-tru and different dose of pCMV-HA-Nsp9. The cells were then treated with 10 µM DMSO or MG132, and the cell lysates were harvested for western blotting analysis with an anti-Myc or anti-HA antibody. The optical density ratios of pRb-tru/β-actin are shown with graphs. (C) Modulation of the ubiquitination of pRb-tru by Nsp9 in HEK 293T cells. HEK 293T cells were co-transfected with the pCMV-Myc-pRb-tru and pCMV-HA-Nsp9. The cells were then treated with DMSO or 10 µM MG132, and the cell lysates were immunoprecipitated with an anti-Myc antibody and probed with anti-ubiquitin and anti-Myc antibodies.

To determine whether Nsp9 promotes the pRb ubiquitination leading to the pRb degradation, HEK 293T cells were co-transfected with pCMV-Myc-pRb-tru and pCMV-HA-Nsp9, and meanwhile, HEK 293T cells were co-transfected with pCMV-Myc-pRb-tru and pCMV-HA as control. The pRb-tru proteins were immunoprecipitated with an anti-Myc antibody and were then detected with an anti-ubiquitin mAb. Compared with the control group, a clear high-molecular-weight smear of the pRb-tru proteins was observed in the presence of the expressed Nsp9, showing that Nsp9 can mediate the ubiquitination of pRb-tru ([Fig. 5](#f0025){ref-type="fig"}C).

Discussion {#s0100}
==========

A number of viruses have been shown to directly or indirectly interact with host cellular proteins to modulate the normal cellular life activities and to facilitate their replications. In this study, we described that the Nsp9 of genotype 2 PRRSV interacted with endogenous and exogenous pRb, one of the key cell-cycle regulating proteins. A conserved motifll-cycle regulating proteins. lar proteins to modulate in the Nsp9-overexpressing cells byRNA-dependent RNA polymerases ([@bib4], [@bib11], [@bib33], [@bib32], [@bib41]). We found the presence of a conserved motif---LACAE in the Nsp9 of genotype 2 PRRSV by aligning the amino acid sequences of the Nsp9 among 17 representative strains of genotype 2 PRRSV. Our results confirmed that the mutation of the conserved residue (*E*) at the position 419 in this motif fully impacted the interaction between Nsp9 and pRb, whereas the substitution of the conserved residues (L and C) at the position 415 and 417 did not affect this interaction, suggesting that the third conserved residue (E) of the LACAE motif plays an essential role in sustaining the interaction between the Nsp9 of genotype 2 PRRSV and pRb. We found no identical or similar LxCxE motif in the Nsp9 of genotype 1 PRRSV. The pRb has shown interaction with histone deacetylase3 (HDAC3) which lacks the LxCxE-like motif ([@bib12]). Thus, whether the Nsp9 of genotype 1 PRRSV interacts with pRb or it shares other motif that binds to pRb needs to be further explored.

A study on mouse hepatitis virus (MHV) showed that the viral protein production was delayed at the presence of the pRb overexpression ([@bib4]). Our results found that the overexpression of exogenous pRb-tru significantly decreased the replication of genotype 2 PRRSV in MARC-145 cells, and silencing the pRb gene obviously increased the viral replication in MARC-145 cells, suggesting that pRb might function as a restriction factor that inhibits the replication of genotype 2 PRRSV. Similar to HCV ([@bib32]), our data indicated that the pRb had a reduced level in PRRSV-infected MARC-145 cells, inferring that the decrease of the pRb abundance is likely required for the replication of PRRSV. The pRb has been shown to regulate the cell cycle and the pRb-E2F pathway plays a vital role in cell cycle progression. Previous studies in some RNA viruses have shown that the interaction of viral proteins with pRb could alter the cell cycle progression to create favorable cellular environment that is beneficial for viral replication ([@bib35], [@bib40], [@bib42]). Thus, we propose that the interaction between the Nsp9 of genotype 2 PRRSV and pRb might modulate the pRb-E2F pathway and altered the cell cycle progression which affects the viral replication. Further investigation for this issue will be required.

Viruses can encode some proteins to degrade the restrictive factors of host and to counteract their inhibition activities on viruses by utilizing ubiquitin proteasome pathway. The E6 of human papillomavirus has been shown to degrade the tumor suppressor p53 through ubiquitin proteasome pathway ([@bib18]). The Vif of human immunodeficiency virus-1 (HIV-1) and the Vpx of HIV and simian immunodeficiency virus (SIV) have been indicated to target APOBEC3G and HD domain-containing protein-1 (SAMHD1) for proteasomal degradation, separately ([@bib1], [@bib21], [@bib27]). Our results clearly showed that the Nsp9 of PRRSV could promote the degradation of pRb by the ubiquitin--proteasome pathway. Thus, we suggest that the ubiquitinational degradation of pRb might be an important mechanism for the PRRSV Nsp9 to counteract the pRb function. The E3 ubiquitin ligase has been recognized as an important component of ubiquitin--proteasome pathway ([@bib9]). Similar to HCV NS5B and CoV-SARS Nsp15 ([@bib4], [@bib32]), we observed that pRb altered its distribution and co-localization with Nsp9 of PRRSV in the cytoplasm following PRRSV infection. Thus, we propose a model that Nsp9 recruited pRb to E3 ligases and modulated E3 ligases dependent degradation of pRb by proteasome pathway in the cytoplasm. It needs to be done to clarify the exact mechanism of the pRb degradation.

The pRb interacts with many cellular regulatory proteins and it participates in cell life activities, including the G1/S transition of cell cycle ([@bib37]), NF-IL6 and IL-8 expression during immune response ([@bib8], [@bib57]) and cell apoptosis ([@bib31], [@bib48]). A further exploration of the mechanisms concerning how the PRRSV Nsp9 affects the pRb function will be necessary to obtain a more detailed understanding of the relationship between viral replication and pRb loss *in vitro*.

Taken as a whole, our findings are the first to indicate that the Nsp9 of genotype 2 PRRSV interacted with pRb, and this interaction promoted the pRb degradation by ubiquitin proteasome pathway in the cytoplasm and benefited viral replication *in vitro*, providing a novel insight for understanding the roles of Nsp9 in the replication and pathogenesis of PRRSV.

Materials and methods {#s0010}
=====================

Cells, virus and antibodies {#s0015}
---------------------------

Porcine pulmonary alveolar macrophages (PAMs) were prepared as previously described ([@bib56]) and maintained in RPMI-1640 medium (Invitrogen, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) (Hyclone Laboratories Inc., South Logan, UT). MARC-145 cells and human embryonic kidney (HEK) 293 T cells were maintained in Dulbecco's modified Eagle medium (DMEM) (Invitrogen) supplemented with 10% FBS at 37 °C. The stock of PRRSV JXwn06 was used in this study ([@bib60]). Mouse anti-HA monoclonal antibody (mAb) (H3663), mouse anti-Myc mAb (M4439), rabbit anti-Myc mAb (C3956), mouse anti-β-actin mAb (A5441) and MG132 (M7449) were all purchased from Sigma--Aldrich (St. Louis, MO). Mouse anti-pRb mAb (\#9309) was purchased from Cell Signaling Technology (Danvers, MA). Rabbit anti-pRb polyclonal antibody (sc-7905) and mouse anti-ubiquitin mAb (P4D1) were purchased from Santa Cruz Biotechnology (Santa Cruz. *CA*). Mouse anti-GFP mAb (66002-1-Ig) and rabbit anti-GFP polyclonal antibody (50430-2-AP) were purchased from Proteintech (Chicago, IL).

Plasmid construction {#s0020}
--------------------

A 1914-nt cDNA fragment of truncated porcine pRb gene (pRb-tru) was amplified from PAMs by RT-PCR with the designed primers 1F/1R ([Table 1](#t0005){ref-type="table"}) according to the porcine pRb gene sequence available in the GenBank database (accession no. XM_001926853.4). The truncated porcine pRb gene was deduced to encode 638 amino acids (aa301--938) with an LxCxE-binding motif. The amplified product was confirmed by sequencing and then subcloned into a lentiviral expression vector pWPXL (Addgene, Cambridge, MA) to generate the pWPXL-pRb-tru-GFP by Pme//Mlu/sites. The pCMV-Myc-pRb-tru was constructed using pCMV-Myc (Clontech Laboratories Inc., Mountain View, CA) with the primers 2F/2R ([Table 1](#t0005){ref-type="table"}) by Bgl///Not/sites. The Nsp9 gene of PRRSV JXwn06 was amplified by PCR using the plasmid pWSK-JXwn as template ([@bib60]) and the primers 3F/3R and 4F/4R, respectively ([Table 1](#t0005){ref-type="table"}). The amplified fragments were subcloned into pWPXL and pCMV-HA (Clontech Laboratories Inc.) by Pme//Mlu/ and Bgl///Not/ sites to generate the plasmids pWPXL-Nsp9-GFP and pCMV-HA-Nsp9, respectively. The mutants of the Nsp9 LACAE motif were generated by overlapping PCR. The pWPXL-Nsp9 (L415A/C417A)--GFP and pCMV-Nsp9 (L415A/C417A)--HA plasmids were constructed by using the primers 5F/5R with alanine substitutions of L415 and C417 ([Table 1](#t0005){ref-type="table"}). The pWPXL-Nsp9 (E419K)--GFP and pCMV-Nsp9 (E419K)--HA plasmids were generated by using the primers 6F/6R with lysine substitution of E419 ([Table 1](#t0005){ref-type="table"}). All the constructed plasmids were confirmed by sequencing.

Preparation of Nsp9-[,]{.ul} Nsp9 (L415A/C417A)-, Nsp9 (E419K)- and pRb-tru-expressing lentiviruses {#s0025}
---------------------------------------------------------------------------------------------------

A lentiviral packaging system including pWPXL (12257), pMD2.G (12259) and psPAX2 (12260) was available from Addgene. The lentivirus-mediated protein expression was performed according to the standard protocol. Briefly, each fragment of Nsp9, Nsp9 (L415A/C417A), Nsp9 (E419K) and pRb-tru was subcloned into the expression vector pWPXL, respectively. The plasmid pWPXL-Nsp9, pWPXL-Nsp9 (L415A/C417A), pWPXL-Nsp9 (E419K), pWPXL-pRb-tru were mixed with pMD2.G and psPAX2 with appropriate proportion, respectively and were then co-transfected into 80% confluence of HEK 293FT cells using the FuGENE HD Transfection Reagents (Roche Applied Science, Indianapolis, IN). The cells were incubated at 37 °C. After a number of syncytias appeared, the supernatants containing lentiviruses were harvested and filtered with a 0.45 filter (Pall Corporation, Port Washington, NY) and were then concentrated by Amicon ultra-100 centrifuge tubes (Mick Millipore, Billerica, MA). The titers of lentiviruses were measured using a QuickTiter™ Lentivirus Titer Kit (Lentivirus-Associated HIV p24) (Cell Biolabs, San Diego, *CA*) and the lentiviruses were stored for use at −80 °C. MARC-145 cells were transduced with the lentiviruses in the presence of 8 μg/mL polybrene (Sigma). Twenty-four hours after the transduction**,** the inoculums were removed and the cells were maintained in DMEM containing 10% FBS.

Co-immunoprecipitation assay {#s0030}
----------------------------

For the co-immunoprecipitation (Co-IP) assay of the Nsp9 and endogenous pRb, MARC-145 cells were transduced with the lentiviruses that were expressing GFP, Nsp9-GFP, Nsp9 (L415A/C417A)--GFP or Nsp9 (E419K)--GFP in the presence of 8 μg/ mL polybrene, respectively. The cells were harvested and lysed in pre-cooled Co-IP lysis buffer (Beyotime, Shanghai, China) at 36 h post-transduction. The cell lysates were precipitated with a anti-GFP mAb in conjunction with Protein A Sepharose (GE Healthcare, Fairfield, CT) overnight at 4 °C with gentle rotation. The beads were washed three times with the lysis buffer, and were then boiled with 5×SDS loading buffer (Beyotime) for 5 min. The eluted proteins from the beads were subjected to western blotting analysis using an anti-pRb or anti-GFP mAb. To distinguish light chain and GFP, an anti-GFP polyclonal antibody was used.

For the Co-IP assay of the Nsp9 and exogenous pRb-tru, HEK 293T cells were co-transfected with pCMV-HA-Nsp9 and pCMV-Myc-pRb-tru, pCMV-HA-Nsp9 (L415A/C417A) and pCMV-Myc-pRb-tru, pCMV-HA-Nsp9 (E419K) and pCMV-Myc-pRb-tru, pCMV-HA-Nsp9 and empty vector, or empty vector and pCMV-Myc-pRb-tru, respectively, using a Lipofectamine^™^ LTX and PLUS^™^ Reagents (Invitrogen). Thirty-six hours after the transfection, the cells were harvested and lysed in pre-cooled Co-IP lysis buffer. The lysates of cells were subjected to Co-IP assays according to HA-Tag IP/Co-IP Application Set instructions (Thermo Fisher, Waltham, MA). The eluted proteins from the beads were subjected to western blotting analysis using an anti-HA or anti-Myc mAb.

Confocal immunofluorescence assay {#s0035}
---------------------------------

For the co-localization analysis of the Nsp9 and exogenous pRb-tru, MARC-145 cells seeded on coverslips in 24-well plates (Corning Inc., Corning, NY) were co-transfected with pCMV-HA-Nsp9 and pCMV-Myc-pRb-tru using the Lipofectamine™ LTX and PLUS™ Reagents when they were grown to approximately 70% confluence. Thirty-six hours after the transfection, the cells were fixed with 100% pre-cooled ethyl alcohol for 15 min at room temperature, and were then washed with PBS for 3 min, and incubated for 1 h at 37 °C with an anti-HA mAb and anti-Myc polyclonal antibody. After washing three times with PBS, the cells were incubated with TRITC-conjugated goat anti-mouse IgG or FITC-conjugated goat anti-rabbit IgG for 1 h at 37 °C. After three washes with PBS, the cells were stained for nuclei with DAPI (Beyotime) for 5 min at room temperature and visualized under a Nikon TE-2000E confocal fluorescence microscope (Nikon Instruments, Inc., Melville, NY).

For the co-localization analysis of the Nsp9 and endogenous pRb, MARC-145 cells and PAMs were infected with the PRRSV JXwn06 at a multiplicity of infection (MOI) of 0.01. Thirty-six hours after the infection, the cells were fixed with 100% pre-cooled ethyl alcohol, and then washed with PBS for 3 min. The cells were probed with an anti-Nsp9 mAb prepared in our laboratory or anti-pRb polyclonal antibody, followed by TRITC-conjugated goat anti-mouse IgG or FITC-conjugated goat anti-rabbit IgG for 1 h at 37 °C. After three washes with PBS, the nuclei were stained with DAPI for 5 min at room temperature and visualized under Nikon TE-2000E confocal fluorescence microscope.

Infection of MARC-145 cells that were expressing pRb-tru with PRRSV {#s0040}
-------------------------------------------------------------------

MARC-145 cells that were seeded into 24-well culture plates were transduced with the lentiviruses expressing pRb-tru. Twenty-four hours after the transduction, the inoculums were removed and the cells were washed three times with PBS, and were then infected with the PRRSV JXwn06 at MOI of 0.01 in DMEM with 5% FBS. After 1 h incubation, the inoculums were removed, and the cells were washed three times with PBS and maintained in DMEM containing 5% FBS. The cells were harvested at 24 h, 36 h and 48 h post-infection, and were then frozen and thawed for three times. After the centrifugation, the culture supernatants were collected and the virus titers (TCID~50~) were determined using a microtitation infection assay. Similarly, the MARC-145 cells with silencing pRb gene were infected with the virus as above described.

Silencing pRb gene with siRNA {#s0045}
-----------------------------

The siRNA for silencing pRb gene were purchased from Shanghai GenePharma (Shanghai, China). MARC-145 cells were treated with 30 pmol of siRNA using the Lipofectamine RNAiMax (Invitrogen) according to the manufacturer's instructions. Forty-eight hours after the treatment, the cell lysates were subjected to western blotting analysis using an anti-pRb antibody. The siRNA target sequences were as follows: sipRb1 (sense), 5′- GGACAUGUGAACUUAUAUATT -3′; sipRb2 (sense), 5′- GCUCUCAGAUUCACCUUUATT -3′; sipRb3 (sense), 5′--CCAGAAGCCAUUGAAAUCUTT-3′; the control siCon (sense), 5′--UUGCGGGUCUAAUCACCGATT-3′.

Infection of MARC-145 cells with PRRSV {#s0050}
--------------------------------------

MARC-145 cells seeded into 6-well culture plates (Corning Inc.) were infected with the PRRSV at MOI of 0.01 in DMEM with 5% FBS. The cells were harvested at 12 h, 24 h, 36 h, 48 h, and 60 h post-infection. The cell lysates were subjected to western blotting analysis using an anti-pRb antibody. Meanwhile, the lysates of mock-infected cells were served as the control.

pRb degradation assay {#s0055}
---------------------

For the endogenous pRb degradation assay, the MARC-145 cells seeded into 6-well culture plates were transduced with the lentiviruses that were expressing Nsp9 or GFP in the presence of 8 μg/mL polybrene. After 24 h, the inoculums were removed and replaced with DMEM containing 10% FBS. The cells were treated with DMSO or 10 µM MG132 for 12 h. The cell lysates were then harvested and subjected to western blotting analysis using an anti-pRb and anti-GFP antibody.

For the exogenous pRb degradation assay, HEK 293T cells seeded into 6-well culture plates were co-transfected with the constant pCMV-Myc-pRb-tru (0.5 µg) and dose-dependent pCMV-HA-Nsp9 (0 µg, 0.5 µg, 1 µg, 1.5 µg, 1.5 µg). The cells were treated with DMSO or 10 µM MG132 for 12 h. The cell lysates were then harvested and subjected to western blotting analysis using an anti-HA or anti-Myc antibody.

The pRb ubiquitination assay {#s0060}
----------------------------

HEK 293T cells seeded into 20 cm^2^ cell culture dish (Corning Inc.) were co-transfected with 3 µg of pCMV-Myc-pRb-tru and 9 µg of pCMV-HA-Nsp9 or empty vector. The cells were treated with 10 µM MG132 for 12 h. The cell lysates were then precipitated with an anti-Myc mAb in conjunction with Protein A Sepharose overnight at 4 °C with gentle rotation. The beads were washed three times with the lysing buffer, and were then boiled with 5×SDS loading buffer for 5 min. The eluted proteins were used for western blotting analysis using an anti-ubiquitin mAb.

Statistical analysis {#s0065}
--------------------

The data were expressed as means±standard deviations (SD). Statistical significance among different groups was determined by Two-way ANOVA test of variance using the GraphPad Prism software (version 5.0). A *P*\<0.05 was considered to be statistically significant.
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[^1]: *F* denotes forward PCR primer; *R* denotes reverse PCR primer.

[^2]: Restriction sites are underlined. Mutated nucleotides are shown as italics.

[^3]: The bold characters denote the motif.
